Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Conversation logo

The world has waited decades for a malaria vaccine, and now two have come along in quick succession. On October 2, the World Health Organization (WHO) recommended that a new malaria vaccine, R21, developed by the University of Oxford be rolled out for the prevention of malaria in children, just two years after another vaccine, the RTS,S, got its endorsement.

In this episode of The Conversation Weekly podcast, we find out why it’s been so hard to find a malaria vaccine – and hear from the scientists behind the new breakthrough.

Read the full article on The Conversation website, featuring: Adrian Hill Director of the Jenner Institute, University of Oxford;  Professor of Epidemiology and Public Health, Malaria Research and Training Center, Université des sciences, des techniques et des technologies de Bamako and Faith Osier Co-Director, Institute of Infection, Chair, Immunology & Vaccinology, Imperial College London

Oxford is a subscribing member of The Conversation. Find out how you can write for The Conversation.